Terms: = Kidney tumors AND SPOP, TEF2, 8405, ENSG00000121067, O43791 AND Treatment
5 results:
1. Deregulation of spop in Cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract] [Full Text] [Related]
2. Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical
Weidle UH; Nopora A
Cancer Genomics Proteomics; 2021; 18(3 Suppl):349-368. PubMed ID: 33994361
[TBL] [Abstract] [Full Text] [Related]
3. Mutated spop E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.
Shi L; Yan Y; He Y; Yan B; Pan Y; Orme JJ; Zhang J; Xu W; Pang J; Huang H
Cancer Res; 2021 Jul; 81(13):3593-3606. PubMed ID: 33762355
[TBL] [Abstract] [Full Text] [Related]
4. The emerging role of spop protein in tumorigenesis and cancer therapy.
Song Y; Xu Y; Pan C; Yan L; Wang ZW; Zhu X
Mol Cancer; 2020 Jan; 19(1):2. PubMed ID: 31901237
[TBL] [Abstract] [Full Text] [Related]
5. Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma.
Adelaiye-Ogala R; Damayanti NP; Orillion AR; Arisa S; Chintala S; Titus MA; Kao C; Pili R
Cancer Res; 2018 Jun; 78(11):2886-2896. PubMed ID: 29572225
[TBL] [Abstract] [Full Text] [Related]